Effect of Preoperative Tramadol and Naproxen Sodium on Post Operative Pain
Symptomatic Irreversible Pulpitis, Post Operative Pain
About this trial
This is an interventional prevention trial for Symptomatic Irreversible Pulpitis focused on measuring Tramadol, Naproxen Sodium, Placebo
Eligibility Criteria
Inclusion Criteria: ASA I and ASA II individuals who are between the ages of 18 and 60 years. Patients who have been diagnosed with symptomatic irreversible pulpitis (with either a normal periapex or symptomatic apical periodontitis). Patients who score moderate to severe (4-10) on a preoperative visual analogue scale (VAS= 1-10). Mandibular permanent premolar and molars. Exclusion Criteria: Patients who had taken painkillers or narcotics in the previous 12 hours Patients suffering from severe pain because of traumatic occlusion. Teeth with extensive damage, calcified canals, root resorption, and an open apex. Previously root canal treated teeth. Medically compromised patients (ASA-III and above) Those with special communication needs or who do not understand Urdu or English language. Pregnant and lactating women Individual patients who will be driving back alone Patients who are allergic to the prescribed medicines
Sites / Locations
- Dow International Dental College
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
Tramadol
Naproxen Sodium
Placebo
Group A will receive premedication of Oral tramadol 100mg,
Group B will receive premedication of oral naproxen sodium 550mg.
Group C, will be the control group and no active preoperative medication will be given to these patients.